Bioorganic and Medicinal Chemistry Letters

Synthesis of a Fluorescent Microgonotropen (FMGT-1) and its Interactions with the Dodecamer d(CCGGAATTCCGG)
pp. 3261-3266(6)
Authors: Satz A.L.; Bruice T.C.

Blockers of Human T Cell Kv1.3 Potassium Channels Using De Novo Ligand Design and Solid-Phase Parallel Combinatorial Chemistry
pp. 3267-3272(6)
Authors: Lew A.; Chamberlin A.R.

Synthesis, Dopamine and Serotonin Transporter Binding Affinities of Novel Analogues of Meperidine
pp. 3273-3276(4)
Authors: Lomenzo S.A.; Izenwasser S.; Gerdes R.M.; Katz J.L.; Kopajtic T.; Trudell M.L.

A One-Step Synthesis of a Deuterated Paclitaxel Analogue: 10-Deacetoxy-(10-²H)paclitaxel
pp. 3277-3278(2)
Authors: Dutta D.; Hadd H.; Vander Velde D.G.; Georg G.I.

Synthesis and Acetylcholinesterase Inhibitory Activity of Huperzine A-E2020 Combined Compound
pp. 3279-3284(6)
Authors: Zeng F.; Jiang H.; Zhai Y.; Zhang H.; Chen K.; Ji R.

Syntheses and Evaluation of Amidinobenzofuran Derivatives as Tryptase Inhibitors
pp. 3285-3290(6)
Authors: Ono S.; Kuwahara S.; Takeuchi M.; Sakashita H.; Naito Y.; Kondo T.

Phomalairdenone: A New Host-Selective Phytotoxin from a Virulent Type of the Blackleg Fungus Phoma Lingam
pp. 3291-3294(4)
Authors: Pedras M.S.C.; Erosa-Lopez C.C.; Quail J.W.; Taylor J.L.

Antiplatelet Actions of Aporphinoids from Formosan Plants
pp. 3295-3300(6)
Authors: Chia Y.-C.; Chen K.-S.; Chang Y.-L.; Teng C.-M.; Wu Y.-C.

Imidazole-Containing Diarylether and Diarylsulfone Inhibitors of Farnesyl-Protein Transferase
pp. 3301-3306(6)
Authors: Dinsmore C.J.; Williams T.M.; O'Neill T.J.; Liu D.; Rands E.; Culberson J.C.; Lobell R.B.; Koblan K.S.; Kohl N.E.; Gibbs J.B.; Oliff A.I.; Graham S.L.; Hartman G.D.

Synthesis and Biological Activities of NB-506 Analogues: Effects of the Positions of two Hydroxyl Groups at the Indole Rings
pp. 3307-3312(6)
Authors: Ohkubo M.; Nishimura T.; Honma T.; Nishimura I.; Ito S.; Yoshinari T.; Suda H.A.H.; Morishima H.; Nishimura S.

Structure-Activity Study of Estrogenic Agonists Bearing Dicarba-Closo-Dodecaborane. Effect of Geometry and Separation Distance of Hydroxyl Groups at the Ends of Molecules
pp. 3313-3318(6)
Authors: Endo Y.; Iijima T.; Yamakoshi Y.; Kubo A.; Itai A.

Antitumor Agents 201. Cytotoxicity of Harmine and -Carboline Analogs
pp. 3319-3324(6)
Authors: Ishida J.; Wang H.-K.; Bastow K.F.; Hu C.-Q.; Lee K.-H.

N-Phenylalkyl-Substituted Tropane Analogs of Boat Conformation with High Selectivity for the Dopamine Versus Serotonin Transporter
pp. 3325-3328(4)
Authors: Prakash K.R.C.; Tamiz A.P.; Araldi G.L.; Zhang M.; Johnson K.M.; Kozikowski A.P.

Synthesis and Biological Activity of a Novel Series of Indole-Derived PPAR Agonists
pp. 3329-3334(6)
Authors: Henke B.R.; Adkison K.K.; Blanchard S.G.; Leesnitzer L.M.; Mook R.A.; Plunket K.D.; Ray J.A.; Roberson C.; Unwalla R.; Willson T.M.

Proteasome Inhibition by the Natural Products Epoxomicin and Dihydroeponemycin: Insights into Specificity and Potency
pp. 3335-3340(6)
Authors: Kim K.B.; Myung J.; Sin N.; Crews C.M.

Probing the Radical Mechanism of Galactose Oxidase Using an Ultrafast Radical Probe
pp. 3341-3346(6)
Authors: Turner B.E.; Branchaud B.P.

Optically Pure (-)-4-[(N-Allyl-3-Methyl-4-Piperidinyl)Phenylamino]-N,N-Diethylbenzamide Displays Selective Binding and Full Agonist Activity for the Opioid Receptor
pp. 3347-3350(4)
Authors: Thomas J.B.; Atkinson R.N.; Herault X.M.; Rothman R.B.; Mascarella S.W.; Dersch C.M.; Xu H.; Horel R.B.; Carroll F.I.

4-Pyridin-5-yl-2-(3,4,5-trimethoxyphenylamino)pyrimidines: Potent and Selective Inhibitors of ZAP 70
pp. 3351-3356(6)
Authors: Moffat D.; Davis P.; Hutchings M.; Davis J.; Berg D.; Batchelor M.; Johnson J.; O'Connell J.; Martin R.; Crabbe T.; Delgado J.; Perry M.

Aptamers Containing Thymidine 3'-O-Phosphorodithioates: Synthesis and Binding to Nuclear Factor-B
pp. 3357-3362(6)
Authors: Yang X.; Fennewald S.; Luxon B.A.; Aronson J.; Herzog N.K.; Gorenstein D.G.

First Fatty Acylated Dipeptides to Affect Muscarinic Receptor Ligand Binding
pp. 3363-3368(6)
Authors: Krishnan V.; Pham W.N.; Messer W.S.; Peseckis S.M.

4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: Selective h5-HT_1D Agonists for the Treatment of Migraine
pp. 3369-3374(6)
Authors: Bourrain S.; Neduvelil J.G.; Beer M.S.; Stanton J.A.; Showell G.A.; MacLeod A.M.

Synthesis and Opiate Receptor Binding Properties of 17-Methyl-6,7-Dehydro-3,14-Dihydroxy-4,5-Epoxy-6,7:4',5'-Pyrimidinomorphin ans
pp. 3375-3380(6)
Authors: Xu W.; Huang L.-F.; Bauer L.; Bhargava H.N.; Dunn W.J.

Reversal of Resistance in Multidrug Resistance Protein (MRP1)-Overexpressing Cells by LY329146
pp. 3381-3386(6)
Authors: Norman B.H.; Dantzig A.H.; Kroin J.S.; Law K.L.; Tabas L.B.; Shepard R.L.; Palkowitz A.D.; Hauser K.L.; Winter M.A.; Sluka J.P.; Starling J.J.